{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:16:58Z","timestamp":1791267418994,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bone.2011.12.013","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T21:06:55Z","timestamp":1325192815000},"page":"954-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)"],"prefix":"10.1016","volume":"50","author":[{"given":"Diah S.","family":"Bramono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadasivam","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bina","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Theng","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zophia Xuehui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Nurcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Cool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2011.12.013_bb0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00264-007-0424-8","article-title":"Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery","volume":"31","author":"Bishop","year":"2007","journal-title":"Int Orthop"},{"key":"10.1016\/j.bone.2011.12.013_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cuor.2007.07.007","article-title":"The use of bone morphogenetic proteins (BMPs) in long-bone non-unions","volume":"21","author":"Dinopoulos","year":"2007","journal-title":"Curr Orthop"},{"key":"10.1016\/j.bone.2011.12.013_bb0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1445-2197.2007.04175.x","article-title":"Bone morphogenetic proteins in clinical applications","volume":"77","author":"Gautschi","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.bone.2011.12.013_bb0020","doi-asserted-by":"crossref","DOI":"10.3310\/hta11300","article-title":"Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review","volume":"11","author":"Garrison","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bone.2011.12.013_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2007.05.029","article-title":"Enhanced bone regeneration with BMP-2 loaded functional nanoparticle\u2013hydrogel complex","volume":"121","author":"Chung","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.bone.2011.12.013_bb0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/bit.21648","article-title":"Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA\/HAp composite scaffolds loaded with BMP-2","volume":"99","author":"Fu","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.bone.2011.12.013_bb0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2008.02.099","article-title":"Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery","volume":"369","author":"Jeon","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2011.12.013_bb0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jbm.a.30728","article-title":"Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo","volume":"78A","author":"Karageorgiou","year":"2006","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.bone.2011.12.013_bb0045","doi-asserted-by":"crossref","first-page":"43229","DOI":"10.1074\/jbc.M300937200","article-title":"Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins","volume":"278","author":"Takada","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0050","series-title":"Essentials of glycobiology","article-title":"Proteins that bind sulfated glycosaminoglycans","author":"Esko","year":"2008"},{"key":"10.1016\/j.bone.2011.12.013_bb0055","doi-asserted-by":"crossref","first-page":"23246","DOI":"10.1074\/jbc.M511039200","article-title":"Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2","volume":"281","author":"Zhao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0060","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1074\/jbc.M109151200","article-title":"Heparan sulfate proteoglycans retain Noggin at the cell surface \u2014 a potential mechanism for shaping bone morphogenetic protein gradients","volume":"277","author":"Paine-Saunders","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00001665-200603000-00013","article-title":"Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction","volume":"17","author":"Arnander","year":"2006","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.bone.2011.12.013_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2004.05.001","article-title":"Imparting bone mineral affinity to osteogenic proteins through heparin\u2013bisphosphonate conjugates","volume":"98","author":"Gittens","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.bone.2011.12.013_bb0075","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.biomaterials.2007.11.032","article-title":"The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2","volume":"29","author":"Lin","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2011.12.013_bb0080","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1073\/pnas.81.4.1030","article-title":"Evaluation of critical groups required for the binding of heparin to antithrombin","volume":"81","author":"Atha","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2011.12.013_bb0085","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0736-0266(02)00072-4","article-title":"Effect of repeated irrigation and debridement on fracture healing in an animal model","volume":"20","author":"Park","year":"2002","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(94)70299-3","article-title":"A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry","volume":"170","author":"Barbour","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bone.2011.12.013_bb0095","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V88.4.1314.bloodjournal8841314","article-title":"Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo","volume":"88","author":"Muir","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bone.2011.12.013_bb0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jbmr.5650070707","article-title":"Effects of heparin on osteoclast activity","volume":"7","author":"Chowdhury","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.147.3656.407","article-title":"Heparin enhancement of factors stimulating bone resorption in tissue culture","volume":"147","author":"Goldhaber","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.bone.2011.12.013_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bone.2007.04.190","article-title":"Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity","volume":"41","author":"Irie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2011.12.013_bb0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","article-title":"Order out of chaos: assembly of ligand binding sites in heparan sulfate","volume":"71","author":"Esko","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bone.2011.12.013_bb0120","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood.V87.8.3229.bloodjournal8783229","article-title":"Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells","volume":"87","author":"Gupta","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bone.2011.12.013_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jcp.20813","article-title":"Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2","volume":"210","author":"Jackson","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2011.12.013_bb0130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jor.20103","article-title":"The use of heparan sulfate to augment fracture repair in a rat fracture model","volume":"24","author":"Jackson","year":"2006","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0135","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11095-010-0352-y","article-title":"The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells","volume":"28","author":"Bramono","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0140","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1634\/stemcells.2008-0149","article-title":"Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche","volume":"26","author":"Jung","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.bone.2011.12.013_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/GBI.S4273","article-title":"Glycosaminoglycans in human and bovine serum: detection of twenty-four heparan sulfate and chondroitin sulfate motifs including a novel sialic acid-modified chondroitin sulfate linkage hexasaccharide","volume":"2","author":"Lu","year":"2010","journal-title":"Glycobiol Insights"},{"key":"10.1016\/j.bone.2011.12.013_bb0150","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jcb.22340","article-title":"Purification and characterization of heparan sulfate from human primary osteoblasts","volume":"108","author":"Murali","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2011.12.013_bb0155","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1074\/jbc.273.8.4350","article-title":"Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development","volume":"273","author":"Brickman","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0160","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1074\/jbc.M110.148874","article-title":"Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells","volume":"286","author":"Murali","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0003-2697(02)00396-2","article-title":"Protein\u2013heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization","volume":"310","author":"Osmond","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bone.2011.12.013_bb0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/scd.2006.0044","article-title":"Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors","volume":"16","author":"Ng","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bone.2011.12.013_bb0175","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1073\/pnas.89.6.2267","article-title":"A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis","volume":"89","author":"Lidholt","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bone.2011.12.013_bb0180","doi-asserted-by":"crossref","first-page":"19315","DOI":"10.1074\/jbc.M111805200","article-title":"Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF alpha-receptor but not PDGF beta-receptor tyrosine phosphorylation in heparan sulfate-deficient cells \u2014 effects on signal transduction and biological responses","volume":"277","author":"Rolny","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/ten.tea.2009.0390","article-title":"Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2","volume":"16","author":"Yang","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.bone.2011.12.013_bb0190","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1016\/j.biomaterials.2010.07.001","article-title":"Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds","volume":"31","author":"Rai","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2011.12.013_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10520299209110046","article-title":"Modified tetrachrome method for osteoid and defectively mineralized bone in paraffin sections","volume":"67","author":"Ralis","year":"1992","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.bone.2011.12.013_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9673(96)00930-2","article-title":"Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate","volume":"765","author":"Karamanos","year":"1997","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.bone.2011.12.013_bb0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.dental.2005.05.012","article-title":"Fabrication and release behavior of a novel freeze-gelled chitosan\/gamma-PGA scaffold as a carrier for rhBMP-2","volume":"22","author":"Hsieh","year":"2006","journal-title":"Dent Mater"},{"key":"10.1016\/j.bone.2011.12.013_bb0210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1074\/jbc.M513414200","article-title":"Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells","volume":"282","author":"Jiao","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0215","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1091\/mbc.e10-04-0348","article-title":"Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization","volume":"21","author":"Kuo","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bone.2011.12.013_bb0220","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0960-9822(00)80060-3","article-title":"Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides","volume":"9","author":"Guimond","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.bone.2011.12.013_bb0225","series-title":"Heparin-binding protein","author":"Conrad","year":"1998"},{"key":"10.1016\/j.bone.2011.12.013_bb0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tcb.2007.02.006","article-title":"Tinkering with heparan sulfate sulfation to steer development","volume":"17","author":"Gorsi","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bone.2011.12.013_bb0235","doi-asserted-by":"crossref","first-page":"28115","DOI":"10.1074\/jbc.M805338200","article-title":"Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity","volume":"283","author":"de Agostini","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0240","series-title":"Progress in Molecular Biology and Translational Science, Vol 93: Glycosaminoglycans in Development, Health and Disease","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1877-1173(10)93008-1","article-title":"Anticoagulant heparan sulfate: to not clot-or not?","author":"Shworak","year":"2010"},{"key":"10.1016\/j.bone.2011.12.013_bb0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/ac702235u","article-title":"Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate","volume":"80","author":"Korir","year":"2008","journal-title":"Anal Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0250","doi-asserted-by":"crossref","first-page":"20008","DOI":"10.1074\/jbc.M801652200","article-title":"Heparin\/heparan sulfate biosynthesis \u2014 processive formation of N-sulfated domains","volume":"283","author":"Carlsson","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0255","doi-asserted-by":"crossref","first-page":"42355","DOI":"10.1074\/jbc.C400373200","article-title":"Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups","volume":"279","author":"Holmborn","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2011.12.013_bb0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: structure and function","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bone.2011.12.013_bb0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nchembio810","article-title":"Sulfation patterns of glycosaminoglycans encode molecular recognition and activity","volume":"2","author":"Gama","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bone.2011.12.013_bb0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","article-title":"The structure of glycosaminoglycans and their interactions with proteins","volume":"72","author":"Gandhi","year":"2008","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bone.2011.12.013_bb0275","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/glycob\/cwp005","article-title":"Structural and functional changes of sulfated glycosaminoglycans in Xenopus laevis during embryogenesis","volume":"19","author":"Yamada","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.bone.2011.12.013_bb0280","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1089\/ten.2004.10.1623","article-title":"Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells","volume":"10","author":"Byers","year":"2004","journal-title":"Tissue Eng"},{"key":"10.1016\/j.bone.2011.12.013_bb0285","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0736-0266(03)00196-7","article-title":"Altered Cbfa1 expression and biomineralization in an osteosarcoma cell line","volume":"22","author":"Perinpanayagam","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0290","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1359\/jbmr.2002.17.11.1931","article-title":"Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2\/Cbfa1","volume":"17","author":"Byers","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1083\/jcb.200105052","article-title":"Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures","volume":"155","author":"Liu","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2011.12.013_bb0300","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0037-1615222","article-title":"The effects of standard and low molecular weight heparin on bone nodule formation in vitro","volume":"80","author":"Bhandari","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bone.2011.12.013_bb0305","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jcb.20007","article-title":"Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro","volume":"91","author":"Hausser","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2011.12.013_bb0310","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/ndt\/15.11.1847","article-title":"Bone mineral density in haemodialysis patients: a comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound","volume":"15","author":"Arici","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2011.12.013_bb0315","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/2171281a0","article-title":"Effect of heparin on serum calcium concentrations in mice","volume":"217","author":"Bonilla","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.bone.2011.12.013_bb0320","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0009-8981(68)90269-6","article-title":"An investigation into the mechanism of the in vitro fall in rabbit plasma calcium which follows intravenous heparin injection","volume":"19","author":"Goldsmith","year":"1968","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bone.2011.12.013_bb0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0008-6215(95)00263-4","article-title":"Multinuclear magnetic resonance studies of the interaction of inorganic cations with heparin","volume":"278","author":"Rabenstein","year":"1995","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bone.2011.12.013_bb0330","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1074\/jbc.M310691200","article-title":"Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist noggin","volume":"279","author":"Viviano","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211013974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328211013974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:38:13Z","timestamp":1762659493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328211013974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S8756328211013974"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2011.12.013","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2011.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}